[go: up one dir, main page]

CY1114064T1 - COMPOSITION FOR INTERMEDIATE ADMINISTRATION OF FENTANYL - Google Patents

COMPOSITION FOR INTERMEDIATE ADMINISTRATION OF FENTANYL

Info

Publication number
CY1114064T1
CY1114064T1 CY20131100495T CY131100495T CY1114064T1 CY 1114064 T1 CY1114064 T1 CY 1114064T1 CY 20131100495 T CY20131100495 T CY 20131100495T CY 131100495 T CY131100495 T CY 131100495T CY 1114064 T1 CY1114064 T1 CY 1114064T1
Authority
CY
Cyprus
Prior art keywords
group
composition
fentanyl
carbon atoms
alkyl esters
Prior art date
Application number
CY20131100495T
Other languages
Greek (el)
Inventor
S Adam Cantor
W Terrance Ocheltree
A Cynthia Robles
Original Assignee
3M Innovative Properties Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP09176390A external-priority patent/EP2158905B1/en
Application filed by 3M Innovative Properties Company filed Critical 3M Innovative Properties Company
Publication of CY1114064T1 publication Critical patent/CY1114064T1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Η παρούσα αίτηση αναφέρεται σε μία σύνθεση διαδερμικής χορήγησης φαρμάκου που περιλαμβάνει (α) ένα συμπολυμερές το οποίο περιλαμβάνει (i) ένα ή περισσότερα μονομερή Α που επιλέγονται από την ομάδα που αποτελείται από ακρυλικούς αλκυλεστέρες που περιέχουν 4 έως 12 άτομα άνθρακα στην αλκυλομάδα, και μεθακρυλικούς αλκυλεστέρες που περιέχουν 4 έως 12 άτομα άνθρακα στην αλκυλομάδα· και (ii) ένα ή περισσότερα αιθυλενικώς ακόρεστα μονομερή Β συμπολυμερίσιμα με το μονομερές Α· που περιέχουν μία λειτουργική ομάδα που επιλέγεται από την ομάδα που αποτελείται από σουλφοναμίδιο, ουρία, καρβαμιδικό, καρβοξαμίδιο, υδροξύλιο, άμινο και κυανό και (β) περίπου 8% έως περίπου 30% κατά βάρος φεντανύλη με βάση το συνολικό βάρος της σύνθεσης.The present application relates to a transdermal drug delivery composition comprising (a) a copolymer comprising (i) one or more A monomers selected from the group consisting of acrylic alkyl esters containing 4 to 12 carbon atoms in the alkyl group, and methacrylates alkyl esters containing 4 to 12 carbon atoms in the alkyl group; and (ii) one or more ethylenically unsaturated B monomers copolymerizable with monomer A; containing a functional group selected from the group consisting of is melted from sulfonamide, urea, carbamate, carboxamide, hydroxyl, amino and cyano; and (b) about 8% to about 30% by weight of fentanyl based on the total weight of the composition.

CY20131100495T 2000-09-29 2013-06-19 COMPOSITION FOR INTERMEDIATE ADMINISTRATION OF FENTANYL CY1114064T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23697300A 2000-09-29 2000-09-29
US28401701A 2001-04-16 2001-04-16
EP09176390A EP2158905B1 (en) 2000-09-29 2001-09-27 Composition for the Transdermal Delivery of Fentanyl

Publications (1)

Publication Number Publication Date
CY1114064T1 true CY1114064T1 (en) 2016-07-27

Family

ID=58449015

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20131100495T CY1114064T1 (en) 2000-09-29 2013-06-19 COMPOSITION FOR INTERMEDIATE ADMINISTRATION OF FENTANYL

Country Status (1)

Country Link
CY (1) CY1114064T1 (en)

Similar Documents

Publication Publication Date Title
CY1118798T1 (en) COMPOSITION OF INTERDERATIVE FINANTYL
JP2004513890A5 (en)
ATE474563T1 (en) HYDROGEL COMPOSITION FOR TRANSDERMAL DRUG DELIVERY
BR0017096B1 (en) pressure sensitive adhesive composition containing radial block and acrylic polymer and pressure sensitive adhesive article containing radial block and acrylic polymer.
KR960700060A (en) TRANSDERMAL THERAPEUTIC SYSTEM WITH GALANTHAMINE AS ACTIVE INGREDIENT
CY1113809T1 (en) Macrocyclic carboxylic acids and acylsulfonamide compounds as inhibitors of HCV replication
ATE243509T1 (en) DRUG PENETRATION ACCELERATOR COMPATIBLE PRESSURE SENSITIVE ADHESIVE
JP2009185061A5 (en)
CY1109272T1 (en) COMPOSITION OF LONG-TERM RELEASE INCLUDING LABIC ACID-GLYCIC ACID COPYMOLYMERS AND METHOD OF PREPARATION
BR9912353A (en) Coating and binding agent for oral and dermal drug forms
EP1681046A3 (en) Cosmetic, pharmaceutical and dermatological compositions containing copolymer waxes
BR0113153B1 (en) process for the production of a polymer dispersion, polymer dispersion, and use thereof.
PE20030066A1 (en) CONTROLLED RELEASE COMPOSITION AND METHOD TO PRODUCE IT
ES2045119T3 (en) BACKGROUND LAYER COMPOSITIONS.
ATE273333T1 (en) (CO-)POLYMERS OF HYDROXYALKYL (METH)ACRYLATES, PROCESS FOR THEIR PRODUCTION AND THEIR USE IN PHARMACEUTICAL DOSAGE FORMS
CY1114064T1 (en) COMPOSITION FOR INTERMEDIATE ADMINISTRATION OF FENTANYL
BRPI0413871A (en) monomer-polymer systems with a controllable working time
MX168322B (en) PRESSURE SENSITIVE THERMOFUSIONABLE ADHESIVES
ATE339991T1 (en) HAIR TREATMENT PRODUCTS CONTAINING ITACONIC ACID MONOESTER/ACRYLATE COPOLYMER AND POLYSTYRENE SULFONATE
DE60127839D1 (en) PLASTER WITH 4-BIPHENYLACETIC ACID
SE0201110D0 (en) New film coating
DE60109780D1 (en) METHOD FOR PRODUCING SOLID PRESSURE-SENSITIVE ADHESIVE POLYMERE MICROBALLS
ATE383380T1 (en) NON-BLOCKING SOLID RESINS OF VINYLESTER MIXED POLYMERS
DE60230408D1 (en) AGAINST SOFTMAKER RESISTANT PRESSURE-RESISTANT ADHESIVE COMPOSITION AND ADHESIVES
CY1111318T1 (en) INTERMEDIATE PHARMACEUTICAL FORM